High-Resolution Three-Dimensional Contrast-Enhanced Blood Oxygenation Level-Dependent Magnetic Resonance Venography of Brain Tumors at 3 Tesla: First Clinical Experience and Comparison with 1.5 Tesla

Rationale and ObjectivesTo evaluate the clinical potential of high-resolution 3D contrast-enhanced blood oxygenation level-dependent MR-Venography (CE-MRV) for primary brain tumors and metastases at 3 Tesla (T) in comparison to 1.5 T. MethodsEighteen patients with brain tumors were examined using CE-MRV after application of a standard dose of MRI contrast agent (0.1 mmol/kg gadodiamide). CE-MRV is based on a high-resolution 3D flow-compensated gradient-echo sequence with long echo times that uses the contrast-enhanced blood oxygenation level-dependent effect. This technique was performed using the same volume coverage and acquisition time at both field strengths after performing standard imaging sequences. ResultsThe higher spatial resolution of CE-MRV at 3 T showed more details within and around tumors than at 1.5 T. Visibility was enhanced by stronger susceptibility weighting and higher intrinsic signal-to-noise at 3 T. Compared with standard imaging protocols, additional information characterized as tubular and nontubular hypointense structures were found within or around lesions on CE-MRV images. ConclusionsAcquisition of CE-MRV data at 3 T enables spatial resolution to be increased within the same measurement time and with the same volume coverage compared with 1.5 T, thus providing more detailed information. The method may also show the potential to estimate oxygen supply of tumors, especially at high field strengths.

[1]  J. R. Reichenbach,et al.  High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique , 2001, Neuroradiology.

[2]  D. Noll,et al.  Homodyne detection in magnetic resonance imaging. , 1991, IEEE transactions on medical imaging.

[3]  F. Howe,et al.  Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. , 1995, International journal of radiation oncology, biology, physics.

[4]  G S Karczmar,et al.  Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. , 1994, Investigative radiology.

[5]  C. Matula,et al.  Magnetic Resonance Imaging Contrast Enhancement of Brain Tumors at 3 Tesla Versus 1.5 Tesla , 2002, Investigative radiology.

[6]  O Salonen,et al.  MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. , 1999, Investigative radiology.

[7]  H. An,et al.  Improving high‐resolution MR bold venographic imaging using a T1 reducing contrast agent , 1999, Journal of magnetic resonance imaging : JMRI.

[8]  J R Griffiths,et al.  Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow. , 1998, Seminars in radiation oncology.

[9]  J. Griffiths,et al.  Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo. , 1998, Cancer research.

[10]  F Barkhof,et al.  MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[11]  J Debus,et al.  [High resolution MR-venography of cerebral arteriovenous malformations]. , 1999, Der Radiologe.

[12]  J. Griffiths,et al.  In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. , 1997, British Journal of Cancer.

[13]  J R Reichenbach,et al.  Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.

[14]  J R Griffiths,et al.  Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. , 1999, Magnetic resonance imaging.

[15]  F. Howe,et al.  Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging , 1999, NMR in biomedicine.

[16]  L R Schad,et al.  Improved target volume characterization in stereotactic treatment planning of brain lesions by using high‐resolution BOLD MR‐venography , 2001, NMR in biomedicine.

[17]  V. Kuperman,et al.  Changes in T2*‐Weighted Images During Hyperoxia Differentiate Tumors from Normal Tissue , 1995, Magnetic resonance in medicine.

[18]  W. Lin,et al.  MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. , 1999, AJNR. American journal of neuroradiology.

[19]  A Abduljalil,et al.  Intracranial ossifications and microangiopathy at 8 Tesla MRI. , 2001, Magnetic resonance imaging.

[20]  J R Reichenbach,et al.  High-Resolution MR Venography at 3.0 Tesla , 2000, Journal of computer assisted tomography.

[21]  N. Yamada,et al.  Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. , 1996, Radiology.

[22]  R. Henry,et al.  Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. , 2000, AJNR. American journal of neuroradiology.

[23]  R I Grossman,et al.  Gliomas: correlation of magnetic susceptibility artifact with histologic grade. , 1997, Radiology.

[24]  S. Holland,et al.  NMR relaxation times in the human brain at 3.0 tesla , 1999, Journal of magnetic resonance imaging : JMRI.

[25]  E. Haacke,et al.  High‐resolution BOLD venographic imaging: a window into brain function , 2001, NMR in biomedicine.

[26]  J R Griffiths,et al.  Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours , 2001, NMR in biomedicine.